ArticleFrontiers in immunology2025

The prognostic power of major pathological response in esophageal squamous cell carcinoma patients undergoing neoadjuvant chemoimmunotherapy: a multi-center cohort study.

Shuhan Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.